tiprankstipranks

Kroeger Christopher A. Insider Profile

4 Followers
Kroeger Christopher A., CEO at Tempest Therapeutics, holds ― shares in Tempest Therapeutics (Ticker: TPST), holds 1.75M shares in MapLight Therapeutics, Inc. (Ticker: MPLT). Most recently, Kroeger Christopher A. ― shares of Tempest Therapeutics on ― for an estimated value of ―.
tipranks
Kroeger Christopher A.

Kroeger Christopher A.
Tempest Therapeutics (TPST)
CEO

Not Ranked
Kroeger Christopher A. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$51M
100.00%
0.00%
A breakdown of Kroeger Christopher A.'s holdings

Insider Roles

MapLight Therapeutics, Inc.
(MPLT)
CEO, Director
Tempest Therapeutics
(TPST)
CEO
Roles that Kroeger Christopher A. holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Kroeger Christopher A.

Kroeger Christopher A.'s Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Tempest Therapeutics
CEO
MapLight Therapeutics, Inc.
Feb 09, 2026
CEO, Director
Uninformative Buy
$51.50M
List of latest transactions for each holding click on a transaction to see Kroeger Christopher A.'s performance on stock

Kroeger Christopher A. insider profile FAQ

What is the percentage of profitable transactions made by Kroeger Christopher A.?
The percentage of profitable transactions made by Kroeger Christopher A. is ―.
    What is the average return per transaction made by Kroeger Christopher A.?
    The average return per transaction made by Kroeger Christopher A. is ―.
      What stocks does Kroeger Christopher A. hold?
      Kroeger Christopher A. holds: TPST, MPLT stocks.
        What was Kroeger Christopher A.’s latest transaction?
        Kroeger Christopher A. latest transaction was an Uninformative Buy of ―.
          What was Kroeger Christopher A.'s most profitable transaction?
          Kroeger Christopher A.’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Kroeger Christopher A.'s role in Tempest Therapeutics?
            Kroeger Christopher A.'s role in Tempest Therapeutics is CEO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.